( ISSN 2277 - 9809 (online) ISSN 2348 - 9359 (Print) ) New DOI : 10.32804/IRJMSH

Impact Factor* - 6.2311


**Need Help in Content editing, Data Analysis.

Research Gateway

Adv For Editing Content

   No of Download : 79    Submit Your Rating     Cite This   Download        Certificate

STUDY TO ASSESS THE IMPACT OF HOME CARE NURSING STRATEGIES ON DIABETES MELLITUS

    2 Author(s):  ALEXIE ALEX,DR.S.PARIMALA

Vol -  11, Issue- 1 ,         Page(s) : 210 - 216  (2020 ) DOI : https://doi.org/10.32804/IRJMSH

Abstract

Diabetic peripheral neuropathy creates in up to half surprisingly with diabetes and is one of the primary hazard factors adding to foot ulceration and possible removal. There are a few sorts of neuropathies yet 90% of individuals with diabetic peripheral neuropathy have symmetric distal polyneuropathy, regularly happening in blend with autonomic neuropathy. The danger of creating diabetic neuropathy is corresponding to both the extent and length of hyperglycaemia along these lines it is more outlandish in individuals with ideal long haul control of HbA1c levels (< 55 mmol/mol). Other hazard factors incorporate smoking, hypertension, corpulence and dyslipidaemia, expanding age and a family ancestry of neuropathy.

• Lindström, J., Louheranta, A., Mannelin, M., Rastas, M., Salminen, V., Eriksson, J., Uusitupa, M., and Tuomilehto, J., 2003. The Finnish Diabetes Prevention Study (DPS) Lifestyle intervention and 3-year results on diet and physical activi- ty. Diabetes care, 26(12), pp.3230-3236.
• Lozeron, P., Nahum, L., Lacroix, C., Ropert, A., Guglielmi, J.M., and Said, G.,2018. Symptomatic diabetic and non-diabetic neuropathies in a series of 100 diabetic patients. Journal of neurology, 249(5), pp.569-575.
• Lunn, M.P., Hughes, R.A. and Wiffen, P.J., 2014. Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. Cochrane Database Syst Rev, 1.
• Lunn, M.P., Hughes, R.A. and Wiffen, P.J., 2014. Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. Cochrane Database Syst Rev, 1.
• Marcus, D.A., 2007. Pain in the Foot.  A headache and Chronic Pain Syn- dromes: The Case-Based Guide to Targeted Assessment and Treatment, pp.131-149.
• Martin, C.L., Albers, J., Herman, W.H., Cleary, P., Waberski, B., Greene, D.A., Stevens, M.J. and Feldman, E.L., 2006. Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion. Diabetes care,
• 29(2), pp.340-344.Martini, C., Yassen, A., Olsen, E., Passier, P., Stoker, M. and Dahan, A., 2012. Pharmacodynamic analysis of the analgesic effect of capsaicin 8% patch (Qutenza™) in diabetic neuropathic pain patients: Detection of distinct response groups. Journal of pain research, 5, p.51.
• Meijer, J.W., van Sonderen, E., Blaauwwiekel, E.E., Smit, A.J., Groothoff, J.W., Eisma, W.H. and Links, T.P., 2000. Diabetic neuropathy examination: a hierar-
• chical scoring system to diagnose distal polyneuropathy in diabetes. Diabetes Care, 23(6), pp.750-753.
• Moore, D.J., Gregory, J.M., Kumah-Crystal, Y.A. and Simmons, J.H., 2009. Mit- igating micro and macrovascular complications of diabetes beginning in adoles- cence. Vascular health and risk management, 5, p.1015.
• Nahorski, M.S., Emery, E.C. and Woods, C.G., Genetics of Pain Insensitivity. eLS. Lin, H.C. and Quan, D., 2011. Diabetic Neuropathy. Medscape Reference.
• Oertel, B.G., and Lötsch, J., 2013. Clinical pharmacology of analgesics as- sessed with human experimental pain models: bridging basic and clinical re- search. British journal of pharmacology, 168(3), pp.534-553.

*Contents are provided by Authors of articles. Please contact us if you having any query.






Bank Details